1 in 8 US adults have taken Ozempic or another GLP-1 drug, KFF survey finds
About 1 in 8 adults in the United States have used a GLP-1 drug like Ozempic or Mounjaro at some point in their lives, and half of them—about 6% of …
About 1 in 8 adults in the United States have used a GLP-1 drug like Ozempic or Mounjaro at some point in their lives, and half of them—about 6% of …
About 1 in 8 adults in the United States have used a GLP-1 drug like Ozempic or Mounjaro at some point in their lives, and half of them—about 6% of …
GLP-1/GIP receptor agonists, including semaglutide (Ozempic) and the investigational retatrutide, represent a seismic shift in cardiometabolic and comorbidity treatment. Over the past decade, the emerging drug class has been robustly …